{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:11:04Z","timestamp":1767665464054},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"19-20","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s10354-010-0807-0","type":"journal-article","created":{"date-parts":[[2010,8,16]],"date-time":"2010-08-16T04:52:48Z","timestamp":1281934368000},"page":"483-486","source":"Crossref","is-referenced-by-count":2,"title":["Hormonelle Kontrazeption und Brustkrebsrisiko"],"prefix":"10.1007","volume":"160","author":[{"given":"Vesna","family":"Bjelic-Radisic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Petru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,1]]},"reference":[{"key":"807_CR1","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer (CGHFBC). Breast cancer and hormonal contraceptives: collaborative reanalyses of individual data on 53297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet, 347: 1713\u20131727, 1996","journal-title":"Lancet"},{"key":"807_CR2","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/1097-0142(195609\/10)9:5<927::AID-CNCR2820090510>3.0.CO;2-3","volume":"9","author":"AM Lilienfeld","year":"1956","unstructured":"Lilienfeld AM. The relationship of cancer of the female breast to artificial menopause and martial status. Cancer, 9: 927\u2013934, 1956","journal-title":"Cancer"},{"key":"807_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJM198501173120303","volume":"312","author":"WD Dupont","year":"1985","unstructured":"Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med, 312: 146\u2013151, 1985","journal-title":"N Engl J Med"},{"key":"807_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0378-5122(87)90063-6","volume":"9","author":"KL Bland","year":"1987","unstructured":"Bland KL. Risk factors as an indicator for breast cancer screening in asymptomatic patients. Maturitas, 9: 135\u2013161, 1987","journal-title":"Maturitas"},{"key":"807_CR5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/oxfordjournals.aje.a117079","volume":"139","author":"B Rosner","year":"1994","unstructured":"Rosner B, Colditz GA, Willett WC. Reproductive risk factors in a prospective study of breast cancer: the Nurses Health Study. Am J Epidemiol, 139: 315\u2013329, 1994","journal-title":"Am J Epidemiol"},{"key":"807_CR6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/oxfordjournals.aje.a115132","volume":"129","author":"DR Miller","year":"1989","unstructured":"Miller DR, Rosenberg L, Kaufman DW, et al. Breast cancer before age 45 and oral contraceptive use: new findings. Am J Epidemiol, 129: 269\u2013280, 1989","journal-title":"Am J Epidemiol"},{"key":"807_CR7","first-page":"973","volume":"i","author":"UK National Case-Control Study Group","year":"1989","unstructured":"UK National Case-Control Study Group. Oral contraceptive use and breast cancer risk in young women. Lancet, i: 973\u2013982, 1989","journal-title":"Lancet"},{"key":"807_CR8","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S0140-6736(86)90166-2","volume":"ii","author":"O Meirik","year":"1986","unstructured":"Meirik O, Lund E, Adami H-O, et al. Oral contraceptive use and breast cancer in young women: a joint national case-control study in Sweden and Norway. Lancet, ii: 650\u2013654, 1986","journal-title":"Lancet"},{"key":"807_CR9","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1136\/bmj.282.6282.2089","volume":"282","author":"Royal College of General Practitioners","year":"1981","unstructured":"Royal College of General Practitioners. Breast cancer and oral contraceptives: Findings in Royal College of General Proacticioners' Study. Br Med J, 282: 2089\u20132093, 1981","journal-title":"Br Med J"},{"key":"807_CR10","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/bjc.1988.285","volume":"58","author":"CR Kay","year":"1988","unstructured":"Kay CR, Hannaford PC. Breast cancer and the pill-a further report from the Royal College of General Practicioners Oral Contraception Study. Br J Cancer, 58: 675\u2013680, 1988","journal-title":"Br J Cancer"},{"key":"807_CR11","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1056\/NEJMoa013202","volume":"346","author":"PA Marchbanks","year":"2002","unstructured":"Marchbanks PA, McDonald JA, Wilson HG, et al. Oral contraceptives and the risk of breast cancer. N Engl J Med, 346: 2025\u20132032, 2002","journal-title":"N Engl J Med"},{"key":"807_CR12","first-page":"1375","volume":"11","author":"M Kumle","year":"2002","unstructured":"Kumle M, Weiderpass E, Braaten T, et al. Use of oral contraceptives and breast cancer risk, the Norwegian-Swedish Women's Lifestyle and Health Cohort Study. Cancer Epidemiol, 11: 1375\u20131381, 2002","journal-title":"Cancer Epidemiol"},{"key":"807_CR13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1158\/1055-9965.EPI-04-0376","volume":"14","author":"RL Milne","year":"2005","unstructured":"Milne RL, Knight JA, John EM, et al. Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol, 14: 350\u2013356, 2005","journal-title":"Cancer Epidemiol"},{"key":"807_CR14","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1136\/bmj.299.6714.1487","volume":"299","author":"MP Vessey","year":"1989","unstructured":"Vessey MP, Villard-Mackintosh L, McPherson K, et al. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study. BMJ 299: 1487\u20131491, 1989","journal-title":"BMJ"},{"key":"807_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/bmj.318.7176.96","volume":"318","author":"V Beral","year":"1999","unstructured":"Beral V, Hermon C, Kay C, et al. Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46000 women from Royal College of General Practicioners' Oral Contraception Study. BMJ, 318: 96\u2013100, 1999","journal-title":"BMJ"},{"key":"807_CR16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/oxfordjournals.aje.a010219","volume":"151","author":"S Shapiro","year":"2000","unstructured":"Shapiro S, Rosenberg L, Hoffman M, et al. Risk of brest cancer in relation to the use of injectable progestogen contraceptives and combined estrogen\/progestogen contraceptives. Am J Epidemiol, 151: 396\u2013403, 2000","journal-title":"Am J Epidemiol"},{"key":"807_CR17","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1001\/jama.1995.03520340055036","volume":"273","author":"DC Skegg","year":"1995","unstructured":"Skegg DC, Noonan EA, Paul C, et al. Depot medroxyprogesterone acetate and breast cancer. A pooled analysis of the World Health Organization and New Zealand studies. JAMA, 273: 799\u2013804, 1995","journal-title":"JAMA"},{"key":"807_CR18","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/01.AOG.0000178754.88912.b9","volume":"106","author":"T Backman","year":"2005","unstructured":"Backman T, Rauramo I, Jaakkola K, et al. Use of the levonorgestrel-releasing intrauterine system and breast cancer. Obstet Gynecol, 106: 813\u2013817, 2005","journal-title":"Obstet Gynecol"},{"key":"807_CR19","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1001\/jama.284.14.1791","volume":"284","author":"D Grabick","year":"2000","unstructured":"Grabick D, Hartmann L, Cerhan J, et al. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA, 284: 1791\u20131798, 2000","journal-title":"JAMA"},{"key":"807_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.contraception.2009.04.010","volume":"80","author":"ME Gaffield","year":"2009","unstructured":"Gaffield ME, Culwell KR, Ravi A. Oral contraceptives and family history of breast cancer. Contraception, 80: 372\u2013380, 2009","journal-title":"Contraception"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-010-0807-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-010-0807-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-010-0807-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T12:03:53Z","timestamp":1559131433000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-010-0807-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":20,"journal-issue":{"issue":"19-20","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["807"],"URL":"https:\/\/doi.org\/10.1007\/s10354-010-0807-0","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}